ORAMED PHARMACEUTICALS INC.
Oramed Pharmaceuticals, established in 2006, developed a proprietary platform for oral delivery of drugs typically administered by injection. Their flagship product is oral insulin (ORMD-0801) for type 2 diabetes, with ongoing clinical trials under the FDA, and ORMD-0901, an oral GLP-1 analog. Oramed aims to improve lives worldwide by transforming injectable treatments into oral therapies.
Official Registry
AI Quality Analysis
Trust Score Breakdown
Quick Links
Website Highlights
🌟 Similar Trusted Businesses
PLUS THERAPEUTICS, INC.
Plus Therapeutics is a clinical-stage pharmaceutical company focusing on developing targeted radiotherapeutics for cancer treatment. They leverage novel drug formulations and technologies to deliver a single, safe, and effective dose of radiation directly to the tumor. Their focus is on improving the treatment of challenging cancers in adults and children, aiming to lengthen and improve lives.
Anebulo Pharmaceuticals, Inc.
Anebulo Pharmaceuticals develops innovative therapies to improve the lives of patients struggling with unintentional cannabis poisoning and acute cannabinoid intoxication. They focus on developing best-in-class therapeutics for treating acute cannabinoid toxicities, particularly in children. The company prioritizes the development of Selonabant.
OVATION SCIENCE INC.
Ovation Science Inc. leverages its patented Invisicare® technology to enhance the delivery of drugs and ingredients through the skin. They provide pharmaceutical-grade technology to global licensees, resulting in high-quality, efficacious topical and transdermal products. They are positioned as an innovative player in the drug development and cannabis industries.